Trials / Terminated
TerminatedNCT00355758
UCI 03-72 Prostate Cancer Detection by Serum Proteomic Profiling
Prostate Cancer Detection by Serum Proteomic Profiling
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- University of California, Irvine · Academic / Other
- Sex
- Male
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
: Researchers would like to see if a new test called SELDI (Surface Enhanced Laser Desorption Ionization) analysis can predict biopsy results better than PSA tests.
Detailed description
A blood sample of approximately 30 cc will be collected prior to the patients standard of care radical prostatectomy surgery. This blood will be used for the SELDI analysis. The remainder of the blood sample will be stored and may be used for the PSA test at a later date. The patient will have a final blood draw 3 months to 1 year following surgery.
Conditions
Timeline
- Start date
- 2005-04-01
- Completion
- 2009-06-01
- First posted
- 2006-07-25
- Last updated
- 2010-09-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00355758. Inclusion in this directory is not an endorsement.